MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Medication fatigue is an unavoidable reality of life with chronic illness
by Mark Harrington on June 17, 2026 at 2:00 pmHere’s a riddle: What has more compartments than a tackle box, more variety than a buffet, and takes longer to sort than a load of laundry you’ve ignored until you ran out of clean underwear? If you said my weekly pill organizer, congratulations! You clearly know me or someone like me. Every week, I sit The post Medication fatigue is an unavoidable reality of life with chronic illness appeared first on Myasthenia Gravis News.
- Model may predict treatment outcomes in ocular myasthenia gravis
by Margarida Maia, PhD on June 17, 2026 at 12:00 pmA simple model that uses five clinical factors could help doctors predict which people with ocular myasthenia gravis (OMG) are most likely to achieve minimal symptoms or better within one year, according to a study in China. “Based on prognostic predictions, early efforts can be made to develop therapeutic interventions that are more specific to individual The post Model may predict treatment outcomes in ocular myasthenia gravis appeared first on Myasthenia Gravis News.
- My daughter’s MG diagnosis led her down a path of helping others
by Dana Enders on June 17, 2026 at 11:00 amIn recognition of Myasthenia Gravis Awareness Month in June, the Myasthenia Gravis Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by myasthenia gravis, written in their own words. Follow us on Facebook, Instagram, or X for more stories like this, using the hashtag #MGAwarenessMonth, or read the full series. In 2020, my The post My daughter’s MG diagnosis led her down a path of helping others appeared first on Myasthenia Gravis News.
- Approved MS therapy found in clinical trial to ease disease severity in MG
by Lila Levinson, PhD on June 16, 2026 at 1:45 pmUblituximab-xiiy, an approved medication for certain types of multiple sclerosis (MS), was shown to safely and effectively reduce disease severity in people with myasthenia gravis (MG) who have self-reactive antibodies against the acetylcholine receptor (AChR) protein. That’s according to new data from an early-stage clinical trial that tested the MS therapy, sold under the brand The post Approved MS therapy found in clinical trial to ease disease severity in MG appeared first on Myasthenia Gravis News.
- 6 safe ways to exercise with myasthenia gravis
by Roslyn Marano on June 16, 2026 at 11:00 amMyasthenia gravis (MG) can cause unpredictable fatigue and muscle weakness, which may make exercise with MG feel intimidating. However, limited research suggests that safe, well-chosen activities can support strength, mobility, and overall well-being. While exercise won’t treat MG directly, mindful movement may help you feel more confident. Before beginning a new physical activity, talk with The post 6 safe ways to exercise with myasthenia gravis appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.